Active

GESTIPHAR

Switched

BE0538550235

Rechtspersoon Besloten Vennootschap 1 establishment

Active for

12 year, 7 months

Registered office

Rue de Marchiennes 4

6044 Charleroi

België

Names & denominations

GESTIPHAR

Official name

FR

Enterprise details

Enterprise type

Rechtspersoon

Legal form

Besloten Vennootschap

Legal situation

Normale toestand

Start date

12 September 2013

Contact

Not specified

Peppol

Active
0208:0538550235

Active since 26 Nov 2025

Powered by

Databakkes.be

Company info. No nonsense.

Activities

NACE-BEL activity descriptions are currently shown in Dutch. English translations are underway.

NACE-BEL activities

What does this company officially do?

47730 Main activity

Detailhandel in farmaceutische producten

70200 Main activity

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

70220 Main activity

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

What are NACE codes? NACE-BEL is the Belgian version of the European activity nomenclature. Each company has at least one code indicating its main activity.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Marchiennes 4

6044 Charleroi

2.223.142.901

Rue de Leernes(GTX) 196

6030 Charleroi

Active since 1 October 2013

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Frequently asked questions

What is the enterprise number of GESTIPHAR?
The enterprise number of GESTIPHAR is BE0538550235.
What is the address of GESTIPHAR?
The registered office of GESTIPHAR is located at Rue de Marchiennes 4, 6044 Charleroi.
When was GESTIPHAR founded?
GESTIPHAR was founded on 12 September 2013.
What is the main activity of GESTIPHAR?
The main activity of GESTIPHAR is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does GESTIPHAR have a website?
No website is currently known for GESTIPHAR.